“干细胞研究与器官修复” 重点专项2022 年度项目申报指南 (征求意见稿)

2022-02-10 网络 网络

2022年2月8日,国家科技部发布关于对国家重点研发计划

2022年2月8日,国家科技部发布关于对国家重点研发计划干细胞研究与器官修复””等5个重点专项 2022 年度项目申报指南征求意见的通知。

 

征求意见时间:2022年2月8日 至 2022年2月14日

意见截止时间:2022年2月14日24点

电子邮箱:jcs_zdxmc@most.cn

主要任务和涵盖热点:

指南围绕“干细胞命运调控及机理”、“干细胞与器官的发生与衰老”、“器官的原位再生与机理”、“复杂器官制造与功能重塑”和“基于干细胞的疾病模型”等五大任务。

涵盖热点包括:类器官、器官芯片,外囊泡(外泌体)、干细胞与器官抗衰老、器官原位再生、干细胞和生物材料

图片

图片

图片

图片

图片

图片

 

图片

图片

图片

图片

图片

图片

图片

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 一己怀

    非常棒!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 一己怀

    学习学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 yesaisai133

    有帮助

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 189284f6f7m

    非常棒!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2009781, encodeId=b91c2009e8176, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50352, encryptionId=8d6750352ef, topicName=征求意见稿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 07 22:51:55 CST 2023, time=2023-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719418, encodeId=30f51e19418f6, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Mon Oct 10 07:51:55 CST 2022, time=2022-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50351, encryptionId=f8c0503517b, topicName=征求意见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Sep 26 04:51:55 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688587, encodeId=084e168858e82, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Sun Jul 17 09:51:55 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192083, encodeId=6f32119208372, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:46 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192082, encodeId=d31011920820c, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Feb 10 22:51:43 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192118, encodeId=5e191192118e1, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Thu Feb 10 23:53:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192078, encodeId=322411920e8c3, content=非常棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40252879905, createdName=189284f6f7m, createdTime=Thu Feb 10 22:32:15 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192053, encodeId=a145119205387, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Thu Feb 10 22:00:22 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 ms5000000018187740

    学习学习

    0

相关资讯

中医药现代化、生殖健康等12个国家重点研发计划重点专项2018年申报指南

各省、自治区、直辖市及计划单列市科技厅(委、局),新疆生产建设兵团科技局,国务院各有关部门科技主管司局,各有关单位:

国家重点研发计划公布 曹雪涛项目拿到近3千万

国家重点研发计划5个重点专项安排公示,曹雪涛负责项目获得了2863万的中央财政经费拨款。

科技部又公布两批国家重点专项评审专家名单,共117人

国家重点研发计划政府间/港澳台重点专项项目评审专家名单公告

2018年国家重点研发计划重点专项已公示立项项目统计•科研院所篇

已公示的2018年国家重点研发计划重点专项43个,公示项目达到770个,拟安排中央财政经费达到142.89亿元。其中,项目牵头承担单位中170多家院所承担246个项目,经费46.11亿元,占重点专项总经费的32.27%。

3.9亿支持13个变革性技术研发 4项与医学相关

国拨3.9亿支持13个变革性技术关键科学问题研发,重点专项将围绕化学键精准重构、超构材料、器官精确介观测量等13个研究方向,其中有4项与医学相关。

国家重点研发计划12个重点专项2018年项目申报指南

  1. 申报单位根据指南支持方向的研究内容以项目形式组织申报,项目可下设课题。项目应整体申报,须覆盖相应指南方向的全部考核指标。项目申报单位推荐1名科研人员作为项目负责人,每个课题设1名负责人,项目负责人可担任其中1个课题负责人。        2. 项目的组织实施应整合集成全国相关领域的优势创新团队,聚焦研发问题,强化基